Vicki Moore, PhD

Contributing Writer https://www.hematologyadvisor.com

Vicki Moore, PhD, is a freelance medical writer for Hematology Advisor. Vicki received her PhD in biology from Arizona State University, where her research emphasized molecular biology, biochemistry, and metabolic engineering. She also has experience with predictive analytics and is intrigued by its applications to medicine. Vicki has been a medical writer, focusing on areas of hematology and oncology, among other specialties, since late 2017. You can find her on Linkedin at linkedin.com/in/vicki-moore-93950913

All articles by Vicki Moore, PhD

Myeloma

Subcutaneous Daratumumab Linked to Shorter Clinic Times for Patients With Multiple Myeloma

Vicki Moore, PhD

March 15, 2023

Researchers sought to determine whether a different administration of daratumumab would lead to shorter clinic times for patients with multiple myeloma.

A nurse speaks with a female teen patient.

Bleeding Disorders

Study Shows Positive Long-Term Efficacy and Safety With Romiplostim for Immune Thrombocytopenia

Vicki Moore, PhD

March 14, 2023

Researchers sought to determine whether romiplostim would be effective in treating pediatric patients with immune thrombocytopenia.

Bleeding Disorders

Gene Therapy Etranacogene Dezaparvovec Shows Favorable Safety for Patients With Hemophilia B

Vicki Moore, PhD

March 10, 2023

Researchers sought to determine whether etranacogene dezaparvovec would be safe for treating patients with hemophilia B.

Myelodysplastic Syndromes

Invasive Aspergillosis Linked With Risk of Death in Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Vicki Moore, PhD

March 9, 2023

Researchers sought to determine whether invasive aspergillosis had a link with risk of death in older patients with AML or MDS.

General Hematology

Gaps in Understanding of Palliative Care Hinders Its Use Among Nurse Practitioners

Vicki Moore, PhD

March 3, 2023

Researchers investigated potential gaps in understanding of palliative care among nurse practitioners in oncology at a large US-based cancer center.

Though lymphoproliferative diseases during pregnancy can lead to complications, a host of treatment options exists.

Thalassemias

In Utero Transfusions Support Improved Survival in Patients With Alpha Thalassemia Major

Vicki Moore, PhD

March 2, 2023

Researchers sought to determine whether in utero transfusions would yield improved survival for patients with alpha thalassemia major.

Doctor examining elderly patient with COVID.

General Hematology

COVID-19 Pandemic-Era Financial Burden High in Survivors of Blood and Marrow Transplantation

Vicki Moore, PhD

March 2, 2023

Researchers sought to determine the medical costs for survivors of blood or marrow transplantation during a period of the COVID-19 pandemic.

Leukemia

CAR-T Survival Outcomes Unrelated to Household Poverty and Neighborhood Opportunity in ALL

Vicki Moore, PhD

February 28, 2023

Researchers sought to determine whether OS rates with CAR-T therapy were linked to household poverty and neighborhood opportunity for patients with ALL.